Doctor profile · Federal record
Dr. HOWARD ADLER, M.D.
Medical Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Medical Oncology Physician · Specialist · Internal Medicine Physician · Hematology (Internal Medicine) Physician · DELRAY BEACH, FL
- NPI 1427006782
- Accepts Medicare
- MIPS 69.1 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6282 LINTON BLVD
DELRAY BEACH, FL 334846416
(561) 495-8307
fax (561) 495-6422
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- December 22, 2021
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (3)
- Florida #71996 · Florida #ME71996 · Florida #71196
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1427006782. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,012
Distinct HCPCS
10
Medicare allowed
$173,044
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 470 | 227 | $102 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 443 | 261 | $69 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 318 | 212 | $69 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 306 | 149 | $101 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 170 | 98 | $52 | |
99221 |
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 56 | 54 | $88 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 52 | 31 | $83 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 46 | 46 | $88 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 46 | 46 | $140 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 31 | 31 | $137 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 168. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$1,475
Transactions
48
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 4 | $143.43 | |
| PFIZER INC. | 6 | $136.92 | |
| Merck Sharp & Dohme LLC | 4 | $109.23 | |
| GENZYME CORPORATION | 4 | $98.14 | |
| Incyte Corporation | 3 | $82.66 | |
| Astellas Pharma US Inc | 4 | $76.10 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70.98 | |
| AstraZeneca Pharmaceuticals LP | 3 | $68.78 | |
| Celgene Corporation | 3 | $61.14 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $60.43 | |
| Genentech USA, Inc. | 2 | $53.54 | |
| Mirati Therapeutics, Inc. | 2 | $51.53 | |
| EMD Serono, Inc. | 2 | $50.36 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48.05 | |
| Novartis Pharmaceuticals Corporation | 3 | $43.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
425
Patients
39
Total drug cost
$3,647,461
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 126 | 39 | $4,860 |
| Venclexta (Venetoclax) | Brand | 39 | 0 | $533,189 |
| Calquence (Acalabrutinib Maleate) | Brand | 36 | 0 | $555,008 |
| Imbruvica (Ibrutinib) | Brand | 33 | 0 | $590,221 |
| Imatinib Mesylate | Generic | 29 | 0 | $21,830 |
| Brukinsa (Zanubrutinib) | Brand | 24 | 0 | $362,743 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 21 | 0 | $321,342 |
| Lenalidomide | Generic | 19 | 0 | $274,436 |
| Revlimid (Lenalidomide) | Brand | 18 | 0 | $328,881 |
| Dexamethasone | Generic | 17 | 0 | $275 |